Globus Medical (GMED) Net Income towards Common Stockholders Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Globus Medical | 10.79 Bn | 10.16 Bn | 525.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.35% |
| Dec 31, 2025 | 27.63% |
| Sep 30, 2025 | 21.89% |
| Jun 30, 2025 | 63.64% |
| Mar 31, 2025 | 23.80% |
| Dec 31, 2024 | -7.47% |
| Sep 30, 2024 | 6.24% |
| Jun 30, 2024 | -3.61% |
| Mar 31, 2024 | -17.23% |
| Dec 31, 2023 | 15.81% |
| Sep 30, 2023 | -50.97% |
| Jun 30, 2023 | 5.11% |
| Mar 31, 2023 | 4.44% |
| Dec 31, 2022 | -11.08% |
| Sep 30, 2022 | 13.13% |
| Jun 30, 2022 | 13.75% |
| Mar 31, 2022 | 5.81% |
| Dec 31, 2021 | -16.05% |
| Sep 30, 2021 | 12.48% |
| Jun 30, 2021 | 9.99% |
| Mar 31, 2021 | 10.11% |
| Dec 31, 2020 | -36.26% |
| Sep 30, 2020 | 10.80% |
| Jun 30, 2020 | -23.44% |
| Mar 31, 2020 | 1.03% |
| Dec 31, 2019 | 7.17% |
| Sep 30, 2019 | 10.68% |
| Jun 30, 2019 | 13.07% |
| Mar 31, 2019 | 9.46% |
| Dec 31, 2018 | -60.48% |
| Sep 30, 2018 | 11.63% |
| Jun 30, 2018 | 43.37% |
| Mar 31, 2018 | 14.73% |
| Dec 31, 2017 | 19.16% |
| Sep 30, 2017 | 9.19% |
| Jun 30, 2017 | 8.57% |
| Mar 31, 2017 | 10.32% |
| Dec 31, 2016 | 12.36% |
| Sep 30, 2016 | 9.24% |
| Jun 30, 2016 | 10.14% |